Decision Aid for Elective Egg Freezing
DAEEF
Knowledge, Decision-making, and Oocyte Cryopreservation Outcomes in Taiwanese Women Considering Elective Egg Freezing: a Randomized Controlled Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether a culturally tailored decision aid can improve decision-making and clinical outcomes for Taiwanese women considering elective egg freezing. The main questions it aims to answer are: Does the decision aid improve women's knowledge about elective egg freezing and help clarify their personal values? Does the decision aid reduce decision regret and psychological distress after making a decision about egg freezing? Researchers will compare women who use the decision aid with those who receive standard counseling to see if the tool improves knowledge, reduces distress and regret, and leads to better clinical outcomes (such as completing egg freezing or achieving a higher number of frozen oocytes). Participants will:
- Complete questionnaires assessing their baseline knowledge, attitudes, and values regarding egg freezing
- Receive either the decision aid or standard counseling
- Complete follow-up questionnaires to assess knowledge, distress, and decision regret
- Have their clinical outcomes recorded, including whether they undergo egg freezing and the number of oocytes retrieved and frozen
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2026
CompletedStudy Start
First participant enrolled
April 13, 2026
CompletedFirst Posted
Study publicly available on registry
April 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2031
April 21, 2026
April 1, 2026
3.3 years
April 9, 2026
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decision Regret Scale
The Decision Regret Scale (DRS) is a 5-item validated questionnaire used to assess distress or remorse after a healthcare decision. Each item is scored on a 5-point Likert scale. Scores are transformed to a 0-100 scale, with higher scores indicating greater decision regret (worse outcome).
6 months, 24 months
Secondary Outcomes (6)
Knowledge score regarding elective egg freezing
baseline, 6 months, 24 months
Decisional conflict scale
baseline, 6 months, 24 months
Depression anxiety stress scale
baseline, 6 months, 24 months
Elective egg freezing treatment completion rate
From enrollment to the end of intervention at 2 years.
Number of oocytes cryopreserved per participant
From enrollment to the end of intervention at 2 years.
- +1 more secondary outcomes
Other Outcomes (1)
Elective egg freezing attitudes and expectations (qualitative assessment)
baseline, 6 months, 24 months
Study Arms (2)
Decision Aid
EXPERIMENTALControl
NO INTERVENTIONInterventions
The EEF decision aid used in this study is an evidence-based educational tool designed to support shared decision making. Its primary function is to provide clear, balanced, and structured information to help women make decisions that align with their personal values and reproductive goals.
Eligibility Criteria
You may qualify if:
- Women aged 20 years or older.
- Currently considering elective egg freezing (EEF).
- Able to communicate and read Chinese fluently.
- Have access to the internet and a mobile device (smartphone, tablet, or computer) to complete online questionnaires.
You may not qualify if:
- Individuals who have previously completed oocyte cryopreservation.
- Women undergoing fertility preservation due to malignancy (i.e., breast cancer).
- Postmenopausal women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan, 100, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2026
First Posted
April 21, 2026
Study Start
April 13, 2026
Primary Completion (Estimated)
July 31, 2029
Study Completion (Estimated)
December 31, 2031
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
De-identified individual participant data (IPD) will not be made publicly available due to the sensitive nature of the data, which includes personal reproductive decision-making, psychological assessments, and qualitative responses that may carry a risk of re-identification.